Suppr超能文献

标准操作规程:急性运动过度性运动障碍

SOP: acute hyperkinetic movement disorders.

作者信息

Sauerbier Anna, Gronostay Alexandra, Dafsari Haidar S

机构信息

Faculty of Medicine, Department of Neurology, University of Cologne, University Hospital Cologne, Cologne, Germany.

Department of Neurology, University Hospital Cologne, Kerpener Str. 62, 50937, Cologne, Germany.

出版信息

Neurol Res Pract. 2023 Jul 27;5(1):35. doi: 10.1186/s42466-023-00260-w.

Abstract

INTRODUCTION

Movement disorders emergencies describe acute-onset neurological conditions in which a delay of recognition and treatment may cause severe morbidity and mortality of patients. Hyperkinetic movement disorders include tremor, chorea/ballism, dystonia, myoclonus, and tics. Here we present a standard operating procedure (SOP) for the diagnostic work-up and different treatment options depending on the phenomenology as well as the aetiology of underlying diseases.

COMMENTS

The recognition of the phenomenology is essential for the symptomatic therapy of the acute movement disorder and forms the basis for the choice of ancillary investigations to confirm the suspected underlying causes. Furthermore, we summarise diagnostic techniques, including blood and cerebrospinal fluid tests and neuroimaging, which provide rapid results and are useful for the indication of causal treatments of specific acute movement disorders.

CONCLUSIONS

Despite their acute nature, most of these conditions can result in good clinical outcomes, if recognised early.

摘要

引言

运动障碍急症描述的是急性起病的神经系统疾病,其中识别和治疗的延迟可能导致患者出现严重的发病率和死亡率。运动过多性运动障碍包括震颤、舞蹈症/投掷症、肌张力障碍、肌阵挛和抽搐。在此,我们根据潜在疾病的现象学以及病因,介绍一种诊断检查的标准操作程序(SOP)和不同的治疗选择。

评论

现象学的识别对于急性运动障碍的对症治疗至关重要,并且是选择辅助检查以确认疑似潜在病因的基础。此外,我们总结了诊断技术,包括血液和脑脊液检查以及神经影像学检查,这些检查能提供快速结果,有助于明确特定急性运动障碍的病因治疗。

结论

尽管这些疾病具有急性性质,但如果能早期识别,大多数情况下可取得良好的临床疗效。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b219/10373268/d3b619b569db/42466_2023_260_Figa_HTML.jpg

相似文献

1
SOP: acute hyperkinetic movement disorders.
Neurol Res Pract. 2023 Jul 27;5(1):35. doi: 10.1186/s42466-023-00260-w.
2
Hyperkinetic Movement Disorder Emergencies.
Curr Neurol Neurosci Rep. 2017 Jan;17(1):6. doi: 10.1007/s11910-017-0712-7.
3
Chapter 33: the history of movement disorders.
Handb Clin Neurol. 2010;95:501-46. doi: 10.1016/S0072-9752(08)02133-7.
4
What is new in tics, dystonia and chorea?
Clin Med (Lond). 2016 Aug;16(4):383-9. doi: 10.7861/clinmedicine.16-4-383.
5
The diagnostic value of clinical neurophysiology in hyperkinetic movement disorders: A systematic review.
Parkinsonism Relat Disord. 2021 Aug;89:176-185. doi: 10.1016/j.parkreldis.2021.07.033. Epub 2021 Jul 31.
6
Treatment of hyperkinetic movement disorders.
Neurol Clin. 1990 Feb;8(1):51-75.
7
The clinical approach to movement disorders.
Nat Rev Neurol. 2010 Jan;6(1):29-37. doi: 10.1038/nrneurol.2009.196.
8
6: Movement disorders II: the hyperkinetic disorders.
Med J Aust. 2001 Apr 16;174(8):413-9. doi: 10.5694/j.1326-5377.2001.tb143349.x.
9
[Laboratory diagnosis of hyperkinetic movement disorders in adulthood].
Nervenarzt. 2002 Feb;73(2):133-43. doi: 10.1007/s00115-001-1256-1.
10
Movement disorder emergencies.
J Neurol. 2008 Aug;255 Suppl 4:2-13. doi: 10.1007/s00415-008-4002-9.

引用本文的文献

1
Atrophy related neuroimaging biomarkers for neurological and cognitive function in Wilson disease.
Neurol Res Pract. 2025 Jul 1;7(1):47. doi: 10.1186/s42466-025-00401-3.

本文引用的文献

1
SOP: antibody-associated autoimmune encephalitis.
Neurol Res Pract. 2020 Jan 15;2:1. doi: 10.1186/s42466-019-0048-7. eCollection 2020.
2
Multidisciplinary inpatient rehabilitation for Functional Movement Disorders: A prospective study with long term follow up.
Parkinsonism Relat Disord. 2021 Jan;82:50-55. doi: 10.1016/j.parkreldis.2020.11.018. Epub 2020 Nov 21.
3
Treatment of Secondary Chorea: A Review of the Current Literature.
Tremor Other Hyperkinet Mov (N Y). 2020 Jul 16;10:22. doi: 10.5334/tohm.351.
4
Emergency presentations of movement disorders.
Pract Neurol. 2020 Aug;20(4). doi: 10.1136/practneurol-2019-002277. Epub 2020 Apr 16.
5
Chemical management of levodopa-induced dyskinesia in Parkinson's disease patients.
Expert Opin Pharmacother. 2019 Feb;20(2):219-230. doi: 10.1080/14656566.2018.1543407. Epub 2018 Nov 9.
6
Levodopa-induced dyskinesia in Parkinson disease: Current and evolving concepts.
Ann Neurol. 2018 Dec;84(6):797-811. doi: 10.1002/ana.25364. Epub 2018 Nov 30.
7
Movement disorders in emergency settings: a prospective study.
Neurol Sci. 2019 Jan;40(1):133-138. doi: 10.1007/s10072-018-3601-1. Epub 2018 Oct 15.
8
Pharmacological interventions for psychosis in Parkinson's disease patients.
Expert Opin Pharmacother. 2018 Apr;19(5):499-505. doi: 10.1080/14656566.2018.1445721. Epub 2018 Mar 1.
9
Anticholinergic medication for antipsychotic-induced tardive dyskinesia.
Cochrane Database Syst Rev. 2018 Jan 17;1(1):CD000204. doi: 10.1002/14651858.CD000204.pub2.
10
Movement disorders and stroke.
Rev Neurol (Paris). 2016 Aug-Sep;172(8-9):483-487. doi: 10.1016/j.neurol.2016.07.006. Epub 2016 Jul 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验